Literature DB >> 1158622

Puerperal endometritis and intrauterine adhesions.

W Z Polishuk, S O Anteby, D Weinstein.   

Abstract

The role of puerperal endometritis in intrauterine adhesion formation was studied by hysterography in 171 women who had cesarean sections. Of 28 patients who developed significant endometritis, only one developed intracervical adhesions. In the control group of 143 cases, there was also only one such case. Endometritis alone apparently does not play a significant role in intrauterine and endocervical adhesion formation. The possible role of placental fibroblasts in preventing endometrial regeneration is discussed.

Entities:  

Mesh:

Year:  1975        PMID: 1158622

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  5 in total

1.  Infectious Inflammatory Processes and the Role of Bioactive Agent Released from Imino-Chitosan Derivatives Experimental and Theoretical Aspects.

Authors:  Loredana Himiniuc; Razvan Socolov; Vlad Ghizdovat; Maricel Agop; Emil Anton; Bogdan Toma; Lacramioara Ochiuz; Decebal Vasincu; Ovidiu Popa; Viviana Onofrei
Journal:  Polymers (Basel)       Date:  2022-04-30       Impact factor: 4.967

Review 2.  Efficacy of intrauterine device in the treatment of intrauterine adhesions.

Authors:  Umme Salma; Min Xue; Ali Sheikh Md Sayed; Dabao Xu
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

3.  The association between menstrual cycle pattern and hysteroscopic march classification with endometrial thickness among infertile women with Asherman syndrome.

Authors:  Saeed Baradwan; Afnan Baradwan; Dania Al-Jaroudi
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

Review 4.  The management of Asherman syndrome: a review of literature.

Authors:  Alessandro Conforti; Carlo Alviggi; Antonio Mollo; Giuseppe De Placido; Adam Magos
Journal:  Reprod Biol Endocrinol       Date:  2013-12-27       Impact factor: 5.211

Review 5.  Adult stem cells in endometrial regeneration: Molecular insights and clinical applications.

Authors:  Qiaoying Lv; Lulu Wang; Xuezhen Luo; Xiaojun Chen
Journal:  Mol Reprod Dev       Date:  2021-05-20       Impact factor: 2.609

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.